Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling.

Chen HangShanojie ZhaoTiejun WangYan Zhang

Published in: Cancer cell international (2021)

Collectively, these results imply that UBE3C plays crucial roles in BrCa development and progression and that UBE3C may be a novel target for the prevention and treatment of BrCa.

Keyphrases

breast cancer risk
stem cells
signaling pathway
cell proliferation
transcription factor
combination therapy
replacement therapy
childhood cancer